fbpx

News

The Augurex team brings together leading scientific, clinical, technical and commercial expertise to ensure that our research translates into advanced diagnostics for improved patient outcomes.

Prev Next

Digital Technology Supercluster Member Spotlight

Did you miss the Digital Technology Supercluster Member Spotlight on Augurex?  Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric...

read more
B.C.’s Most Influential Women 2018: Stem Stars

B.C.’s Most Influential Women 2018: Stem Stars

Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We're so proud of our CEO Norma Biln being recognized by BC Business as a vital contributor to Women in Tech: [button...

read more
2018 Ready to Rocket Winner

2018 Ready to Rocket Winner

Honored to be recognized by "Ready to Rocket" as one of the 10 featured Life Sciences companies to experience accelerated growth. We're excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles technology...

read more
Canada’s Most Powerful Women: Top 100 Current Winners

Canada’s Most Powerful Women: Top 100 Current Winners

Augurex CEO Norma Biln was awarded Canada's Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others.  The Top 100 Award Winner community now includes 1,005 remarkable women who together celebrate accomplishments, share...

read more
USPTO Issues 14-3-3η Patent: Good News for RA Patients

USPTO Issues 14-3-3η Patent: Good News for RA Patients

NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC —  Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes.  Today the U.S Patent and Trademark Office (USPTO) has issued...

read more

Digital Technology Supercluster Member Spotlight

Did you miss the Digital Technology Supercluster Member Spotlight on Augurex?  Read how Augurex will be working alongside Supercluster members like Telus Health, Providence Health Care, Microsoft and LifeLabs Medical Laboratory Services to advance patient-centric...

read more
B.C.’s Most Influential Women 2018: Stem Stars

B.C.’s Most Influential Women 2018: Stem Stars

Working in STEM means that you’re innovative, you’re creative, you’re passionate, you’re clever, you’re whoever you want to be. We're so proud of our CEO Norma Biln being recognized by BC Business as a vital contributor to Women in Tech: [button...

read more
2018 Ready to Rocket Winner

2018 Ready to Rocket Winner

Honored to be recognized by "Ready to Rocket" as one of the 10 featured Life Sciences companies to experience accelerated growth. We're excited for the future! About Ready to Rocket: Ready to Rocket is a unique business recognition list that profiles technology...

read more
Canada’s Most Powerful Women: Top 100 Current Winners

Canada’s Most Powerful Women: Top 100 Current Winners

Augurex CEO Norma Biln was awarded Canada's Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others.  The Top 100 Award Winner community now includes 1,005 remarkable women who together celebrate accomplishments, share...

read more
USPTO Issues 14-3-3η Patent: Good News for RA Patients

USPTO Issues 14-3-3η Patent: Good News for RA Patients

NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC —  Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes.  Today the U.S Patent and Trademark Office (USPTO) has issued...

read more

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Sign Up for Updates

* indicates required
Terms

Home

Products

Science

About

News

Careers

Contact

220 – 887 Great Northern Way
Vancouver, BC, V5T 4T5

Phone: 604.637.3280